Descriptor English: | Leukotriene D4 | ||||||
Descriptor Spanish: |
Leucotrieno D4
| ||||||
Descriptor Portuguese: | Leucotrieno D4 | ||||||
Descriptor French: | Leucotriène D4 | ||||||
Entry term(s): |
LTD4 Leukotriene D Leukotriene D 4 Leukotriene D-4 Leukotrienes D |
||||||
Tree number(s): |
D10.251.355.255.100.450.855.461 D10.251.355.310.166.887.855.461 D23.469.050.175.450.725.415 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017998 | ||||||
Scope note: | One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990) |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Registry Number: | 73836-78-9 | ||||||
CAS Type 1 Name: | Glycine, N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)-, (R-(R*,S*-(E,E,Z,Z)))- | ||||||
Previous Indexing: |
SRS-A (1982-1993) |
||||||
Public MeSH Note: | 94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93 |
||||||
Online Note: | use SRS-A to search LEUKOTRIENE D4 & LEUKOTRIENES D 1983-93 |
||||||
History Note: | 94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93 |
||||||
DeCS ID: | 31349 | ||||||
Unique ID: | D017998 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1994/01/01 | ||||||
Date of Entry: | 1993/06/04 | ||||||
Revision Date: | 2015/06/08 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Leukotriene D4
- Preferred
Leukotrienes D
- Broader
Concept UI |
M0027179 |
Scope note | One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990) |
Preferred term | Leukotriene D4 |
Entry term(s) |
LTD4 Leukotriene D 4 Leukotriene D-4 |
Concept UI |
M0027180 |
Preferred term | Leukotrienes D |
Entry term(s) |
Leukotriene D |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey